Member Info for maestro1

debt is over $500m, the same as revenue..

A bit high?

the rig should get to site by end of may then fixing and testing the new well, a while to go yet, Andrea shot himself in the foot.

Lets see, him buying shares maybe so he keeps his job.

Hope he is not doing Andrew Bell.. If the city lose confidence in a ceo its very difficult for the company to perform.

bit of resistance but its headed the right way, next 7 months are interesting something gotta give.

While everyone was buying near 4p, Andrea showed the rig installation on twitter which enticed buyers but then issued the raise the next day.

Dirty..

These pills stay in your system for a long time, with the med gel you can live a normal life go on dates, have a meal and then do the hanky panky. With the pills you can't eat etc etc.

The gel has the potential to take alot of the mkt share. We are at the exciting stage..

ajbennett

I owe you apology, what Andrea did was almost unforgivable with that placing, even if it was small.

I truly believe they dont have a clue, this should have been dealt with along time ago, why leave it to the last minute. We need experienced oil and gas CEO, someone who knows what he is doing.

Jungmana

If this hits 6p before spud, i will eat my hat. Andrea has killed market sentiment with his antics. Just when we started getting momentum and confidence from the investor community he pulls this.

Mudstud

lol, you are right, i dont trust Andrea now.i believe they dont have funds to deepen both c37 and c30. imho

Icos sold 50% of asset for $75m at the development phase and they were not in the final phase of trials.

"Analysts said that amount was extremely high for a drug that had not yet entered the final, and most important, phase of clinical trials. In another unusual arrangement, the two companies will share the marketing and sales of the drug in North America and in Europe and split the profits 50-50."

https://www.nytimes.com/1998/10/02/business/lilly-pays-big-fee-up-front-to-share-in-rival-of-viagra.html

Eventually they purchased Icos 50% share for $2.1bn.

I think the market is missing a beat with FUM, the MED2005 actually works, its onset is between 5-10 mins, yet FUM only has a mkt cap of 50m.

Fum may apply for EU license in early 2020 and the USA FDA in late 2020, by then this would be taken over. I think fum made the right decision to go it alone in the final phase.

loz786

"Delivery of the Top Drive system and additional mud system components is expected by the end of May 2019."

By mid june rig fully tested and commence drilling. Add a few days for Andrea factor

https://webcasting.brrmedia.co.uk/broadcast/5c6135aae6e1d92d38f4d01c

41 mins and 40 secs

Ken James believes chances of success are fairly high, this is a given. Phase 2 0.2mg dose was successful but they were told to investigate higher dosages.

As we get closer to the end of 2019 sp will steadily rise, no other topical gel is being formed for ED sufferers at present. med gel is certainly worth more that the current mkt cap based just on potential.

Then no one mentions the TPR100 which has currently going through the regulatory submissions for commercial sales.

Jungmana

Mid June is the earliest possible to drill, so some time to go yet.

Maybe they can replace Andrea in the mean time.

You need to ask the company where the revenue from 250bopd production going?

Do they have enough funds to drill both c37 and C30? I don't think they have...

There latest action has cost them alot of good new investors.

notrac

sorry, to date no adverse effects, they stated in the interview/presentation. All 1000 patients will be enlisted by june. over 500 have been enlisted so far, so they are already on the course, its 12 week course.

The product works, just testing higher dosages.

I think Zen need to get rid of Andrea, that last placing was shady. Also the have joint broker which leads me to believe they may have been struggling to raise funds.

Trust is a major point when you decide to invest but when they pull this off you can't defend.

The last minute addition has delayed drillin by at least 6 weeks.

Delays are part of the game in oil and gas, just when interest was coming in we get this from Zen.

https://www.google.com/amp/s/amp.theguardian.com/lifeandstyle/2017/aug/11/viagra-prescriptions-on-nhs-triple-in-10-years-as-stigma-fades

Interesting, no doubt med gel will benefit.

Thomas

Of course the viagras may work better for the severe users, but for mild/moderate sufferers doctors should recommend the gel as primary.

The key thing with the med gel is that it can work between 5-10mins the tablets can't. Once potential partners get confirmation from these phase 3 studies I can see bidding war.

Like I said in my last post, a large pharmaceutical could benefit by buying the data, even now if fum were to sell it now, certainly worth more than the current mkt cap.

I tend to disagree with you, ed sufferers are forced to use Viagra as nothin else is available. If you ask sufferers what would they prefer to use a gel or take a tablet orally, I can bet vast majority will favour the gel.

Add the fact the gel only take between 5-10 mins to work.

We forget the pain gel, fum are cheap.

Let's put it this way of med2002 was sold today it was certain sell for multiples of current share price.

Imho

Thomas

They are estimating med2002 market share over $1bn, these are big numbers. The market has not catched this yet, FUM are in advance stage of testing this product and they said after a successful phase 3 it will increase med2002 valuation by 50%. The testing is going great with no adverse side effects.

Stock market usually values on future potential, here it is not taking that into account. Fum has said after phase 3 trials they will look to sell or partner up. I get the feeling they will sell.

I believe fum is currently undervalued.

Remember fum said with phase 3 trials complete they could get additional 50% for product than if only phase 2 trials were complete. So well worth doing...

I think med gel will do well, diabetes sufferers who are on blood thinners will suit this gel.

Good chance after these results fum sell the company...

I think if you ask men what would you prefer to use I think the vast majority would say the topical gel.

Apart from oral tablets and injection into the peni s there is not much else available. Going alone by FUM made sense, they are in advance stage of testing and if others try researching for alternative product it will take years to catch up to fum. Even if med2005 works for mild/moderate patients this is a very good product.

I believe fum being very conservative with there 20% market share in the field, I think alot of ed sufferers will prefer to use a gel than take tablets orally.

Fum may get regulatory approval in short time frame after the phase 3 tests.

I truly believe had this been trading in the US market this would have a market cap well over 200m. As we get closer to sept it would carry on surging.

Remember this went to 90p few years back on initial findings of drug working, now they are well advanced so +50p is reasonable. Imho

Well we won't be going up on Monday its bank holiday.

I'm very pleased with this product, if I had to use something for ed and I was given option to use topical gel or tablet I would use the gel no doubt.

Fun thinks they can get $1bn revenues from med2005 per annum. Mkt cap on potential should be higher.